The Legal Herald Logo
Legal Analysis By Attorneys
Breaking Legal News

Aziyo Biologics Recalls FiberCel Fiber Viable Bone Matrix After Post-Surgical Infections Arise

doctor viewing lung x ray of tuberculosis infected patient
Published: June 11, 2021
By: Paul
Last Updated on June 14, 2021

At Least One Lot Of FiberCel Potentially Contaminated

On June 2nd, 2021, the US Food & Drug Administration (FDA) announced the voluntary recall of Aziyo Biologics' FiberCel Fiber Viable Bone Matrix. 

The urgent notification came after one of Aziyo's customers, a hospital, complained that 7 of 23 patients that had received the FiberCel Fiber Viable Bone Matrix graft had developed a post-surgical infection. Of those, four were tested and found to be positive for tuberculosis.

Tuberculosis, often referred to as tb, is a potentially deadly infectious disease that attacks the lungs. It is highly contagious and, if it cannot be properly contained, can wreak havoc on a hospital's population.

For the time being, sales of FiberCel were voluntarily suspended by the manufacturer. Only one donor lot is believed to be responsible for the infections. All customers who are recorded as having taken delivery of said lot were ordered to quarantine the product and ship it back to Aziyo as soon as possible. Affected patients should have also been notified by the hospital of the increased health risks. 

Jeff Gibson - Attorney
Hello, I’m attorney Jeff Gibson.
If you or a loved one were affected by a defective drug or medical device, I’d be happy to discuss your legal options. Call me on the number below. It costs nothing, and it would be my honor to help you.
(877) 671-6480

Wagner Reese LLP Announces Investigation Into Recall Of FiberCel Fiber VBM

Attorney contributor Jeff Gibson, an experienced drug and medical device lawyer, has previously represented individuals who have fallen victim to the negligence of medical device manufacturers. Jeff's law firm, Wagner Reese LLP of Indiana, has been retained by clients to investigate the recent recall of Aziyo Biologics' FiberCel Fiber Viable Bone Matrix (VBM).

"When patients agree to undergo complex medical procedures such as orthotic and spinal surgeries, they place an enormous amount of trust in their doctors. And while it's clear that there is some inherent risk in surgical intervention, patients wholeheartedly expect their health to improve after the procedure is completed. When this doesn't happen, and in fact they end up with new ailments, it's only normal for them to seek answers regarding what went wrong."

"Medical technology has advanced significantly over recent years. This rapid advancement has seen innovative products come onto the market, many of which have had enormous success. Among these new technologies are products that employ donor tissue as a foundation for healing. In other words, the tissue from one individual is used to create a product that is then grafted or implanted into someone else, all with the goal of helping the transplantee to heal faster than ever before."

"Such technology has helped to save many lives. Yet, positive health outcomes should by no means allow the manufacturer of these products to relax their safety standards. Whenever cells, tissue, or blood are transplanted from one individual to another, immense care has to be taken to avoid passing on undesired viruses, bacteria, and other diseases. Tragically, it is now alleged that the use of Aziyo Biologics' FiberCel Fiber Viable Bone Matrix (VBM) resulted in unsuspecting patients suffering post-surgery infections, with some even contracting tuberculosis."

"This end result is absolutely unacceptable and it is exactly why I, along with the team at Wagner Reese LLP, are currently investigating these claims. Our team of experienced legal professionals always aims to get to the bottom of such issues and, if negligence on behalf of any parties is found to have been the culprit, we are proud to stand up and fight to get victims the justice they deserve."

Source:

https://www.fda.gov/vaccines-blood-biologics/recalls-biologics/urgent-voluntary-notification-fibercel-fiber-viable-bone-matrix-fibercel-lot-number-nmds210011

https://theproductlawyers.com/aziyo-biologics-fibercel-fiber-viable-bone-matrix-recall/

Got A Tip Or Questions 
About A Story?
Call Us!
The Legal Herald
888-997-3792
About the Author
Paul
About Paul
Editor: Paul is a staff editor who focuses on bringing you the most important legal news regarding cases of sexual assault, drunk driving, and preventable violence. Contact Paul: [email protected] This article was fact checked prior to publishing by this author to ensure compliance with our rigorous editorial standards. We will only use authoritative sources. Our values compel us to provide only trustworthy information. If you find an error, please contact us.
Read some recent posts
  • Details
  • Incident

Find A Local Lawyer

Want To Contribute Breaking News? 
Contact Us Today
Legal Herald Logo[email protected]
10355 Kensington Shore Dr. #102
Orlando, FL 32827
Call: (888) 997-3792
© 2020 The Legal Herald, a division of Eagle Peak Marketing, LLC. All rights reserved.

We would like our readers to know that the information in this story may be sourced from secondary sources and may therefore contain inaccuracies. We will correct them if and when they are brought to our attention or we discover them through our editing process. If you have any concerns about this post, please contact us immediately and we will rectify issues. DISCLAIMER: The material contained in this post is for general informational purposes. It is not intended to constitute or express legal or medical advice. Any laws referenced herein are substantially based on general legal principles and may not be applicable to your particular situation. Laws can often be different from one jurisdiction to the next. The Legal Herald is not a law firm. Law firms and lawyers from around the country may apply to become a sponsor or contributor to The Legal Herald.
SitemapMedia RoomDisclaimer / Terms Of Service & Privacy Policy